4 studies found for:    16510744 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study to Explore the Onset of Efficacy on Magnetic Resonance Disease Activity of BG00012 (Dimethyl Fumarate) in Patients With Relapsing remitTing Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: BG00012;   Other: Placebo
2 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
3 Completed
Has Results
Natalizumab De-escalation With Interferon Beta-1b
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: interferon beta-1b;   Drug: Natalizumab
4 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo

Indicates status has not been verified in more than two years